特发性肺纤维化
粒体自噬
巨噬细胞极化
癌症研究
细胞生物学
肺纤维化
肌成纤维细胞
核转染
纤维化
生物
巨噬细胞
转染
下调和上调
基因敲除
化学
表观遗传学
小发夹RNA
免疫学
HDAC11型
HDAC6型
组蛋白
自噬
线粒体
表观基因组
人性化鼠标
博莱霉素
作者
Yunjuan Nie,Li Xu,Yanyan Liu,Jiao Li,Zhixu Wang,Xiaorun Zhai,Xiaoru Sun,Chunxiao Hu,Bo Xu,Yaxian Wu,Haitao Yu,Manjula Karpurapu,Huaqi Guo,Gaoshang Chai
标识
DOI:10.1038/s41467-026-71639-x
摘要
Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease where macrophages drive fibrogenesis, yet Hdac11’s role is unclear. We first identify pronounced Hdac11 upregulation in IPF lungs, which is associated with an enrichment in alveolar macrophages (AMs). Genetic ablation of Hdac11 or adoptive transfer of Hdac11-deficient macrophages markedly attenuates fibrosis. Specifically, Hdac11 deficiency significantly reduces M2 macrophage polarization in vivo and vitro and is associated with reduced macrophage-myofibroblast transition (MMT) like phenotypic reprogramming, thereby decreasing myofibroblast accumulation and profibrotic gene expression. Mechanistically, impaired mitophagy mediates Hdac11-mediated M2 macrophage polarization and is associated with MMT-like changes. Hdac11 regulates mitochondrial quality control by deacetylating Parkin at lysine 76, promoting its ubiquitination and degradation, which impairs mitophagy and drives profibrotic macrophage activation. Pharmacological Hdac11 inhibition effectively reverses bleomycin-induced fibrosis. Taken together, our work identifies Hdac11 as a target of Parkin-mediated mitophagy in macrophages, establishing Hdac11-Parkin axis disruption as an important mechanism in IPF and highlighting Hdac11 inhibition as a potential therapeutic strategy. Epigenetic dysregulation is a central driver of the progressive remodeling seen in idiopathic pulmonary fibrosis with specific factors to be further explored. The authors here show Hdac11 drives lung fibrosis by repressing Parkin-dependent mitophagy, which is associated with enhanced macrophage M2-type polarization and myofibroblast trans-differentiation.
科研通智能强力驱动
Strongly Powered by AbleSci AI